Eileen Mcneill

Suggest Changes
Learn More
OBJECTIVE A major site of action for the atheroprotective drug nicotinic acid (NA) is adipose tissue, via the G-protein-coupled receptor, GPR109A. Since, adipose tissue is an active secretory organ(More)